Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

South Florida oncologists are seeing an alarming rise in a hard-to-detect breast cancer that is increasing at more than ...

Health Minister Budi Gunadi Sadikin announced on Friday that around 44.9 million people have registered for the government’s ...

As economic uncertainty deepens, the rush for gold continues — with prices for the precious metal topping $4,300 for the ...

Sound Off is an opinion forum for Mercury readers to offer brief comments on today’s news. Submissions must be 75 words or ...

Could Stanford pursue James Franklin? What about Nick Rolovich for Oregon State and Pat Fitzgerald for UCLA? Could Jedd Fisch ...

Over the past few years, University Hospitals in Cleveland has achieved notable progress — delivering higher-quality care, creating better ...

A new anti-sunscreen movement is gaining momentum. It appears to be driven in part by a growing distrust in some circles of conventional expert health advice and federal regulators. Speaking ...

Removing school vaccine mandates can lead to increased spread of infectious diseases, more hospitalizations and potential ...